tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RPRX Stock Latest News

Royalty Pharma downgraded to Hold from Buy at TD Cowen
The FlyRoyalty Pharma downgraded to Hold from Buy at TD Cowen
15d ago
RPRX
Royalty Pharma 14.244M share Block Trade priced at $40.00
PremiumThe Fly
Royalty Pharma 14.244M share Block Trade priced at $40.00
25d ago
RPRX
Royalty Pharma 14.244M share Block Trade; price range $40.00-$40.78
PremiumThe Fly
Royalty Pharma 14.244M share Block Trade; price range $40.00-$40.78
25d ago
RPRX
Royalty Pharma Reports Strong Q3 2025 Results
PremiumCompany Announcements
Royalty Pharma Reports Strong Q3 2025 Results
26d ago
RPRX
Royalty Pharma’s Q3 2025 Earnings Call Highlights
PremiumCompany Announcements
Royalty Pharma’s Q3 2025 Earnings Call Highlights
26d ago
RPRX
Royalty Pharma reports Q3 portfolio receipts of $814M
PremiumThe FlyRoyalty Pharma reports Q3 portfolio receipts of $814M
27d ago
RPRX
Royalty Pharma raises FY25 portfolio receipts view to $3.2B-$3.25B
Premium
The Fly
Royalty Pharma raises FY25 portfolio receipts view to $3.2B-$3.25B
27d ago
RPRX
Royalty Pharma acquires royalty interest in Alnylam’s AMVUTTRA for $310M
Premium
The Fly
Royalty Pharma acquires royalty interest in Alnylam’s AMVUTTRA for $310M
28d ago
RPRX
Royalty Pharma price target lowered to $54 from $55 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target lowered to $54 from $55 at Morgan Stanley
2M ago
RPRX
Royalty Pharma: Strategic Positioning and Growth Potential Drive Buy Rating
PremiumRatings
Royalty Pharma: Strategic Positioning and Growth Potential Drive Buy Rating
2M ago
RPRX
Royalty Pharma initiated with a Buy at Goldman Sachs
PremiumThe Fly
Royalty Pharma initiated with a Buy at Goldman Sachs
2M ago
RPRX
Royalty Pharma appoints Ted Love as lead independent director
PremiumThe Fly
Royalty Pharma appoints Ted Love as lead independent director
2M ago
RPRX
These 3 “Strong Buy” Value Stocks Have over 30% Upside, According to Analysts – 9/17/2025
PremiumMarket NewsThese 3 “Strong Buy” Value Stocks Have over 30% Upside, According to Analysts – 9/17/2025
2M ago
DOX
ZTO
Royalty Pharma Completes $2 Billion Senior Notes Offering
Premium
Company Announcements
Royalty Pharma Completes $2 Billion Senior Notes Offering
3M ago
8K
RPRX
Royalty Pharma: Strong Performance and Promising Outlook Justify Buy Rating
Premium
Ratings
Royalty Pharma: Strong Performance and Promising Outlook Justify Buy Rating
3M ago
RPRX
Royalty Pharma ‘on track’ to deliver portfolio receipts of $4.7B by 2030
PremiumThe Fly
Royalty Pharma ‘on track’ to deliver portfolio receipts of $4.7B by 2030
3M ago
RPRX
Royalty Pharma’s Strategic Moves and Growth Prospects Justify Buy Rating
PremiumRatings
Royalty Pharma’s Strategic Moves and Growth Prospects Justify Buy Rating
3M ago
RPRX
Zenas BioPharma, Royalty Pharma enter obexelimab funding agreement
PremiumThe Fly
Zenas BioPharma, Royalty Pharma enter obexelimab funding agreement
3M ago
RPRX
ZBIO
Royalty Pharma, Zenas BioPharma enter into obexelimab funding agreement
PremiumThe Fly
Royalty Pharma, Zenas BioPharma enter into obexelimab funding agreement
3M ago
RPRX
ZBIO
Strategic Acquisition and Promising Revenue Growth Drive Buy Rating for Royalty Pharma
PremiumRatingsStrategic Acquisition and Promising Revenue Growth Drive Buy Rating for Royalty Pharma
3M ago
RPRX
Royalty Pharma Stock (RPRX) Rises as it Seals $950M Cancer Royalties Deal with Amgen
Premium
Market News
Royalty Pharma Stock (RPRX) Rises as it Seals $950M Cancer Royalties Deal with Amgen
3M ago
ONC
AMGN
Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
Premium
The Fly
Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
3M ago
ONC
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >